Table 2.
Pre-treatment control site (ASB) |
Pre-treatment experimental site (ATSB) |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Day | Sex | # Tested | # Anthrone + | % Anthrone + | # Col Gut | % Col Gut | Day | Sex | # Tested | # Anthrone + | % Anthrone + | # Col gut | % Col gut |
4 | F | 36 | 21 | 58.33 | N/Aa | N/A | 4 | F | 55 | 38 | 69.01 | N/Aa | N/A |
M | 28 | 18 | 64.29 | N/A | N/A | M | 39 | 29 | 74.36 | N/A | N/A | ||
6 | F | 42 | 20 | 47.62 | N/A | N/A | 6 | F | 27 | 15 | 55.56 | N/A | N/A |
M | 33 | 25 | 75.76 | N/A | N/A | M | 19 | 15 | 78.95 | N/A | N/A | ||
10 | F | 45 | 24 | 53.33 | N/A | N/A | 10 | F | 60 | 42 | 70.00 | N/A | N/A |
M | 29 | 18 | 62.07 | N/A | N/A | M | 48 | 30 | 62.50 | N/A | N/A | ||
12 | F | 62 | 37 | 59.67 | N/A | N/A | 12 | F | 82 | 45 | 54.88 | N/A | N/A |
M | 43 | 38 | 88.37 | N/A | N/A | M | 53 | 36 | 67.92 | N/A | N/A | ||
Total | F | 185 | 102 | 55.14 | N/A | N/A | Total | F | 224 | 140 | 62.50 | N/A | N/A |
M | 133 | 99 | 74.43 | N/A | N/A | M | 159 | 110 | 68.18 | N/A | N/A |
Post-treatment control site (ASB) |
Post-treatment experimental site (ATSB) |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Day | Sex | # Tested | # Anthrone + | % Anthrone + | # Col Gut | % Col Gut | Day | Sex | # Tested | # Anthrone + | % Anthrone + | # Col gut | % Col gut |
18 | F | 40 | 15 | 37.50 | 17 | 42.50 | 18 | F | 44 | 7 | 15.91 | 4 | 9.09 |
M | 32 | 13 | 40.63 | 8 | 25.00 | M | 19 | 8 | 42.11 | 2 | 10.53 | ||
24 | F | 51 | 21 | 41.18 | 15 | 29.41 | 24 | F | 19 | 5 | 26.32 | 1 | 5.26 |
M | 45 | 18 | 40.00 | 13 | 28.89 | M | 8 | 4 | 50.00 | 1 | 12.50 | ||
30 | F | 43 | 16 | 37.12 | 9 | 20.93 | 30 | F | 35 | 15 | 42.86 | 5 | 14.29 |
M | 29 | 7 | 24.14 | 11 | 37.93 | M | 13 | 7 | 53.84 | 3 | 23.08 | ||
36 | F | 35 | 12 | 34.29 | 8 | 22.86 | 36 | F | 15 | 9 | 60.00 | 1 | 6.67 |
M | 28 | 15 | 53.57 | 5 | 17.86 | M | 7 | 3 | 42.86 | 0 | 0.00 | ||
42 | F | 45 | 15 | 33.33 | 10 | 22.22 | 42 | F | 9 | 5 | 55.56 | 2 | 22.22 |
M | 37 | 8 | 21.62 | 7 | 18.92 | M | 4 | 3 | 75.00 | 1 | 25.00 | ||
Total | F | 214 | 79 | 36.16 | 59 | 27.57 | Total | F | 122 | 41 | 33.61 | 13 | 10.66 |
M | 171 | 61 | 35.67 | 44 | 25.73 | M | 51 | 25 | 49.02 | 7 | 13.72 |
N/A–not applicable; No ASB or ATSB sprayed pre-treatment.